SCHEMBL6388179

SCHEMBL6388179

Cc1c(S(=O)(=O)O)ccc2c(=O)[nH]c(=O)n(C)c12

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ADORA2B P29275 3/20 0.35
▸ ADORA2A P29274 2/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ PARG Q86W56 2/20 0.34
▸ CDK1 P06493 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ PMP22 Q01453 1/20 0.33
▸ PDE3A Q14432 1/20 0.32
▸ DRD1 P21728 2/20 0.32
▸ PARP1 P09874 1/20 0.31
▸ EIF2AK2 P19525 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MYC P01106 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6395773 0.81 ADORA2B (0.41) MEN1KMT2AADORA2BADORA2AADORA3
SCHEMBL6389075 0.79 ADORA2B (0.41) MEN1KMT2AADORA2BADORA2AADORA3
SCHEMBL6389174 0.79 ADORA2B (0.35) MEN1KMT2AADORA2BADORA2AADORA3
SCHEMBL6390833 0.77 DAO (0.36) MEN1KMT2AADORA2BADORA2AADORA3
SCHEMBL6394532 0.77 MEN1 (0.38) MEN1KMT2AADORA2BADORA2ACDK1
SCHEMBL6394785 0.77 PARG (0.36) MEN1KMT2AADORA2BPARGPDE3A
SCHEMBL6393958 0.77 PARG (0.34) MEN1KMT2AADORA2BPARGCDK1
SCHEMBL6392081 0.73 ADORA2B (0.41) MEN1KMT2AADORA2BADORA2AADORA3
SCHEMBL6387041 0.71 KMT2A (0.35) MEN1KMT2APARGPARP1
SCHEMBL6390331 0.71 PARG (0.41) PARGPDE3APARP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1237119-C Dopant agent and electroconductive polymer materials comprising the same MITSUI CHEMICALS INC (JP) 2006-01-18 — — CN disclosed
US-20050040373-A1 Dopant and conductive polymer material therewith MITSUI CHEMICALS, INC. (JP) 2005-02-24 — — US disclosed
US-6814888-B2 FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR MITSUI CHEMICALS, INC. (JP) 2004-11-09 — — US disclosed
CN-1462299-A Dopant agent and electroconductive polymer materials comprising the same MITSUI CHEMICALS INC (JP) 2003-12-17 — — CN disclosed
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same MITSUI CHEMICALS, INC. (JP) 2003-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same RPS6, H1-10, H1-0 MEN1 2087/4885KMT2A 1534/4885ADORA2B 2241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback